Parixam Pharmaceuticals Private Limited
About Parixam Pharmaceuticals Private Limited
Data last updated:
Parixam Pharmaceuticals Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24304GJ2017PTC098980.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gadhesaria Rasikbhai Nayan and Kamal Nayan Joshi.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 52 Kalyan Nagar Society Simada Puna, Surat, Gujarat, India – 395010.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.56 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.93 Lakh (net margin 2.5%) and EBITDA of ₹6.17 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 90% over three years and 145% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Parixam Pharmaceuticals Private Limited's registered office is in Surat, Gujarat. Its e-mail address is in the company report.
- Email
- Registered Address52 Kalyan Nagar Society Simada Puna, Surat, Gujarat, India – 395010
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Parixam Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Parixam Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Parixam Pharmaceuticals Private Limited, buy the company report.
Financials of Parixam Pharmaceuticals Private Limited
FY 2023 filings availableParixam Pharmaceuticals Private Limited reported revenue of ₹1.56 Cr (up 1127% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 145% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.93 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Parixam Pharmaceuticals Private Limited, buy the company report.
Board of directors of Parixam Pharmaceuticals Private Limited
Parixam Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Nayan Joshi | Additional Director | 25 Aug 2023 | 3 Years 2 Months | Current |
| Gadhesaria Rasikbhai Nayan Also directs: Kayan Healthcare Private Limited | Director | 07 Sep 2017 | 9 Years 1 Months | Current |
Peer comparison
Parixam Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Parixam Pharmaceuticals Private Limitedthis company | ₹1.56 Cr (FY 2023) | ₹3.93 Lakh | 2.5% | 1127.0% | Surat, Gujarat, India | |
| Xander Pharmaceuticals Private Limited | ₹1.56 Cr (FY 2025) | Perintalmanna, Kerala, India | ||||
| Vivion Pharmaceuticals Private Limited | ₹1.56 Cr (FY 2025) | 15.0% | Jaipur, Rajasthan, India | |||
| Mayapur Merchandise Private Limited | ₹1.56 Cr (FY 2025) | -37.0% | Kolkata, West Bengal, India | |||
| Kelly Pharmaceuticals Private Limited | ₹1.56 Cr (FY 2024) | 19.0% | Uttam Nagar, New Delhi, Delhi, India |
To see the full peer comparison of Parixam Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Parixam Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Parixam Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Parixam Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Parixam Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Divyeshkumar Gadhesariya Rasikbhai ceased to be Director on 25 Aug 2023.
Frequently asked questions
Parixam Pharmaceuticals is an active private limited company based in Surat, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 September 2017 (9+ years old) and is registered under CIN U24304GJ2017PTC098980.
Parixam Pharmaceuticals has 2 current directors:
- Kamal Nayan Joshi - Additional Director
- Gadhesaria Rasikbhai Nayan - Director
The latest financial statements of Parixam Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Parixam Pharmaceuticals is U24304GJ2017PTC098980. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Parixam Pharmaceuticals was incorporated on 07 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Parixam Pharmaceuticals by revenue are Xander Pharmaceuticals Private Limited, Vivion Pharmaceuticals Private Limited, Mayapur Merchandise Private Limited, Kelly Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Divyeshkumar Gadhesariya Rasikbhai ceased to be Director on 25 Aug 2023. Kamal Nayan Joshi was appointed as Additional Director on 25 Aug 2023. Gadhesaria Rasikbhai Nayan was appointed as Director on 07 Sep 2017.
The registered office of Parixam Pharmaceuticals is at 52 Kalyan Nagar Society Simada Puna, Surat, Gujarat, India – 395010.
Parixam Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Parixam Pharmaceuticals is compliant as of 22 August 2026. The company is actively filing with the Registrar of Companies.
Parixam Pharmaceuticals can be reached at its registered office: 52 Kalyan Nagar Society Simada Puna, Surat, Gujarat, India – 395010.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
